ResearcherUniversity of Florida HealthActive in the last 2 years

Guettchina Telisnor

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4764-0171; OpenAlex author ID A5043306655. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

Analysis of pancreatic cancer treatment and survival disparities in Florida throughout the Covid-19 pandemic. Co-author DOI 10.1016/j.jnma.2024.07.004 ↗
Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. Co-author DOI 10.1016/j.jnma.2023.01.008 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sherise Chantell Rogers · 2 shared papers, 2023–2024 · strength 0.43
- Paper Analysis of pancreatic cancer treatment and survival disparities in Florida throughout the Covid-19 pandemic. DOI 10.1016/j.jnma.2024.07.004 ↗
- Paper Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African … DOI 10.1016/j.jnma.2023.01.008 ↗
Ibrahim Nassour · 1 shared paper, 2024 · strength 0.24
- Paper Analysis of pancreatic cancer treatment and survival disparities in Florida throughout the Covid-19 pandemic. DOI 10.1016/j.jnma.2024.07.004 ↗
John M. Allen · 1 shared paper, 2023 · strength 0.18
- Paper Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African … DOI 10.1016/j.jnma.2023.01.008 ↗
Edward Agyare · 1 shared paper, 2023 · strength 0.18
- Paper Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African … DOI 10.1016/j.jnma.2023.01.008 ↗
Thomas J. George · 1 shared paper, 2023 · strength 0.18
- Paper Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African … DOI 10.1016/j.jnma.2023.01.008 ↗
Bo Han · 1 shared paper, 2023 · strength 0.18
- Paper Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African … DOI 10.1016/j.jnma.2023.01.008 ↗
Esther Frimpong · 1 shared paper, 2023 · strength 0.18
- Paper Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African … DOI 10.1016/j.jnma.2023.01.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.